Alexander Kristen has filed 27 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 10617 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 10617 | $0.00 | 58,417.0000 | 363,020,303 | 22.21% | 0.00% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 15926 | $0.00 | 74,343.0000 | 363,020,303 | 27.26% | 0.00% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 19887 | $0.00 | 94,230.0000 | 363,020,303 | 26.75% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | F | Common Stock | 17862 | $0.67 | 76,368.0000 | 363,020,303 | 18.96% | 0.00% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 10617 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.00% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 15926 | $0.00 | 15,927.0000 | 363,020,303 | 50.00% | 0.00% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 19887 | $0.00 | 39,773.0000 | 363,020,303 | 33.33% | 0.01% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | A | Stock Option (Right to Buy) | 185540 | $0.00 | 185,540.0000 | 363,020,303 | 9999.99% | 0.05% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | A | Restricted Stock Units | 185540 | $0.00 | 185,540.0000 | 363,020,303 | 9999.99% | 0.05% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 2700 | $0.00 | 33,050.0000 | 0 | 8.90% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 10616 | $0.00 | 43,666.0000 | 0 | 32.12% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 15927 | $0.00 | 59,593.0000 | 0 | 36.47% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | F | Common Stock | 11793 | $2.62 | 47,800.0000 | 0 | 19.79% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 2700 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 10616 | $0.00 | 10,617.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 15927 | $0.00 | 31,853.0000 | 0 | 33.33% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | A | Restricted Stock Units | 59660 | $0.00 | 59,660.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | A | Stock Option (Right to Buy) | 59660 | $0.00 | 59,660.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 5400 | $0.00 | 22,363.0000 | 0 | 31.83% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 2700 | $0.00 | 25,063.0000 | 0 | 12.07% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Common Stock | 10617 | $0.00 | 35,680.0000 | 0 | 42.36% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | F | Common Stock | 5330 | $2.17 | 30,350.0000 | 0 | 14.94% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 5400 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 2700 | $0.00 | 2,700.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | M | Restricted Stock Units | 10617 | $0.00 | 21,233.0000 | 0 | 33.33% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | A | Restricted Stock Units | 47780 | $0.00 | 47,780.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Alexander Kristen | VP, Finance and Accounting | A | Stock Option (Right to Buy) | 71670 | $0.00 | 71,670.0000 | 0 | 9999.99% | 0.00% |